• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/65

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

65 Cards in this Set

  • Front
  • Back
What is hemostasis?
A combination of cellular & biochemical events that function in harmony to 1. keep blood liquid in veins & arteries; 2. prevent blood loss by thrombi formation; & 3. re-establish blood flow during the healing process.
Cellular elements of hemostasis.
- Vascular intima (blood vessels)
- Blood platelets
- RBCs
- Lymphocytes
- Monocytes
Enzyme systems of hemostasis.
Coagulation/fibrinolysis mechanisms.
Mechanism of primary hemostasis.
Activated by small injuries to blood vessels or damage to endothelial cells--> blood vessel contracts to seal the wound and platelet plug formation.
Characteristic of primary hemostasis d/o.
Mucous membrane hemmorhages.
Mechanism of secondary hemostasis.
- Is triggered directly or by primary hemostasis & is necessary to control bleeding from large wounds incurred through trauma, surgery, or dental procedures.
- Coagulation cascade resulting in the formation of cross-linked fibrin.
Primary procoagulant roles of the blood vessel.
Constrict & provide collagen & other compounds to activate clotting.
Anticogulant properties if intact endothelium.
- Cells are rhomboid, presenting a smooth, contigious surface
- Secretes prostacyclin: plt. activation inhibitor
- Secretes nitric oxide: counteracts vasocnstriction
- Secretes heparan sulfate: slows coagulation by acivating antithrombin.
- Secretes tissue factor pathway inhibitor (TFPI): inactivates coagulation factor VIIa & controls the tissue factor pathway.
- Maintains cell membrane thrombomodulin, protein C coagulation control system activator.
Fibrinolytic properties of the vascular intima.
Secretes tissue plasminogen activator (TPA) w/c binds fibrin & triggers the activation of plasminogen--> plasmin w/c digests the thrombus & re-stores blood flow.
Release process of platelets into peripheral circulation from the bone marrow.
Megakaryocytes cytoplasmic fragments extend through the endothelial cells, lining the sinusoids, into blood & then shed platelets.
Platelet ultrastructures.
- Membrane resembles any biologic membrane; a bilayer composed of proteins & lipids.
- Platelet membrane supports categories of receptors that support the initial phases of plt. adhesion & aggregation.
Most important adhesion receptor.
GP Ib/IX/V= vWF receptor (CD42)
Receptor for fibrinogen.
GP IIb & IIIa- "hidden" receptor in resting plt.; required for plt. aggregation.
Platelet structural zone.
- Consists of microtubules & a network of proteins (maintain plt. shape & contract on activatin to encourage expression of alpha-granule contents)
- Actin is the most abundant protein.
Function of platelet granules.
Serve as storage sites for proteins & other substances essential for platelet function.
Dense bodies (delta granules).
Appear more dense in electron microscope preparations- contain mediators of plt. function & hemostasis that are not proteins (ADP, serotonin, ATP, Ca+ & Mg+).
Alpha granules.
- Most numerous plt. granule contains hemostatic & non-hemostatic proteins.
- Some are synthesized by the plt (vWF & Factor V).
- Others sre absorbed/endocytosed from the plasma (fibrinogen, Ig, albumin)
- Some alpha granule contents are found exclusively in plts (i.e., PF4, PDGF, PAI-1)
Function of platelet derived growth factor (PDGF).
Stimulates smooth muscle to multiply & replace the damaged cells (allowing the vessel to heal).
Primary hemostatic plug.
Is the result of the transformation of plts from an inactive (non-adhesive) to an active (adhesive) state.
Events involved in the normal formation of primary plug.
1. Adhesion
2. Aggregation
3. Granule secretion
4. Secondary hemostasis
Platelet adhesion.
- 1st step in primary plug formation.
- Attachment of plt. to collagen fibers in subendothelium (directly in low shear stress areas)
- Requires the presence of vWF & the GPIb/IX/V receptor (in high shear stress areas to "carpet" the injury site.
- Does not include the secretion of granules.
Agonist.
- Substances that stimulate & activate platelets.
- Collagen, Thrombin, ADP, Epinephrine, Thromboxane A2
Platelet aggregation.
- Attachment of platelets to each other.
- Required the active conformation of the GPIIb/IIIa receptor.
- Part of primary hemostasis (plt-vWF plug)
Platelet secretion.
- Plt granule content d/c into the surrounding area.
- Requires ATP.
- Delta granules release ADP & Calcium necessary for fibrinogen attachment & secondary hemostasis.
- Release of alpha granules --> secondary hemostasis.
Other blood cells role in coagulation.
- RBCs: add bulk to fibrin clot.
- Lymphocytes & monocytes: provide tissue factor that triggers coagulation in inflammation.
Serine proteases.
- Proteolytic enzymes: Factor 2, 7, 9, 10,11, 12, & pre-Kallikrein.
- Function in harmony to form a fibrin clot (secondary hemostasis).
- Absence of a single plasma procoagulant --> lifelong hemorrhage, chronic inflammation, transfusion dependence.
Coagulation system.
- Activation of procoagulants is localized to the site of the injury.
- Occurs on the surface of the plts/endothelial cell membrane phospholipids (not in fluid phase).
Fibrinogen (Factor I).
- Ultimate substrate (acted upon by the enzyme thrombin) of the coagulation pathway.
- The only coagulation protein that does not become an activated enzyme.
- Forms the primary structural protein of the fibrin clot.
- Refrence range: 200-400mg/dL
Zymogens.
Enzymes that circulate in an inactive form.
Cofactors.
- Bind specific serine proteases--> stability & increased reactivity of enzyme.
- Tissue factor, Factor 5, 8, & high molecular weight kininogen (HMWK).
Factor XIIIa.
The only coagulation protein w/ transglutaminase activity- form stable, covalent, fibrin cross links.
Vitamin K dependent.
- Prothrombin (Factor II)
- Factor 7, 9, & 10.
- Regulatory proteins: protein C & S.
Vitamin K.
- Fat soluble vitamin (quinone) found in green leafy vegetables, fish, liver.
- Synthesized by some Gram negative bacteria.
- Catalyzes glutamic acid--> y-carboxyglutamic acid reaction.
Prothrombin group proteins.
Essential post-translation modification= glutamic acid--> y-carboxyglutamic acid (critical for calcium binding properties of Prothrombin group proteins)
Vitamin K deficiency.
- Vitamin K dependent procoagulans released from the liver but unable to participate in coagulation.
- Non-functional; lack COOH group that binda calcium.
Vitamin K antagonist.
Warfarin/Coumadin (oral anti-coagulant therapy).
Fibrinogen group proteins.
- Fibrinogen (Factor I), factors V, VIII, & XIII.
- Acted upon by thrombin.
- Have the highest molecular weights of all factors.
- Not found in serum; consumed during clotting.
von Willibrand Factor (vWF)
- Provides receptor sites for plts (adhesion) & collagen.
- Transports the procoagulant factor VIII.
- Synthesized in megakaryocytes (alpha granules) & endothelial cells.
Factor VIII.
- Labile deteriorates rapidly; depends on vWF for stability.
- Hemophilia A: decreased factor VIII w/ normal vWF levels.
- von Willebrannd Dz: decreased vWF & factor VIII.
Contact factor complex.
- Factor XI, XII, high molecular weight kininogen (HK), & prekallikrein (PK).
- Requires a negatively charged surface for activation (glass, kaolin, ellagic acid).
- Does not require calcium.
- Do not appear to play a major role in vivo except factor XI.
Factor XI activation pathway.
- Activated by thrombin.
- Factor XIa activates fatcor IX--> fibrin stabilization by fatcor XIIIa.
- Essential to normal coagulation.
Four coagulation cascade interacting sets of reactions.
- Complex formation on phospholipid membranes- coagulation occurs on cell surface membranes.
- Intrinsic pathway
- Extrinsic pathway
- Common pathway
Procoaguant complexes assemble on the PL membrane.
- First complex (extrinsic Xase)
- Second complex (intrinsic Xase)
- Third complex (prothrombinase)
Tissue factor pathway: first complex
Membrane receptor for factor VIIIa (in the presence of PL & Ca2+)--> activation of factors 9 & 10.
Tissue factor pathway: second complex
- Factor IXa binds factor VIIIa on PL surface & also activates factor X.
- Factor Xa binds Va on PL surfaces.
Tissue facor pathway: third complex
- Factor Xa/Va complex activates prothrombin= thrombin.
- Thrombin leaves fibrinogen--> fibrin monomer--> polymer
- Factor XIIIa stabilized fibrin polymer.
Thrombin
- Chief protease of coagulation.
- Primary fn.: Cleave fibrinogen molecule--> fibrin monomer.
- Add'l fns.: activates factors V, VIII, XI (amplifies coagulation); activates factor XIII; initiates activation of plts (agonist); activates protein C pathway; activates thrombin activable fibrinolysis inhibitor (TAFI)
Tissue factor pathway inhibitor (TFPI).
- Regulatory mechanism.
- Factor VIIa/tissue factor (first complex)--> activates factor 9 & 10.
- Factor Xa reacts w/ first complex to bind TFPI--> inactivates factor VIIIa--> short lived factor VIIa/tissue factor complex.
Protein C regulatory system.
- Thrombin-thrombomodulin complex--> activates protein C system.
- Activated protein C (APC) binds free plasma protein S--> inactivates Va & VIIIa.
Protein S.
- Binds to & stabilizes APC (cofactor).
- Vitamin K dependent.
- Only free plasma protein S can serve as APC cofactor.
Antithrombin.
- Serine protease inhibitor.
- Binds & neutralizes thrombin, fatcors IXa, Xa, XIa, & XIIa.
- Requires heparin for effective anticoagulant activity.
Other serine protease inhibitors.
- Heparin cofactor II
- Alpha2- macroglobulin.
Plasminogen
- Single chain protein that binds to fibrin during polymerization.
- Converted to plasmin by bound TPA or urokinase.
- Also binds plasma alpha2-antiplasmin, w/c rapidly & irreversibly binds & inactivates free plasmin (prevents systemic activity).
Plasmin
- Serine protease that systematically digests the fibrin polymer.
- Capable of digesting fibrinogen & fatcors V & VIII (known as primary fibrinolysis).
Fibrinolysis.
- Final stage of hemostasis; begins few hours after fibrin polymerization.
- Function: reduce thrombus/clot & re-stre normal blood flow during vascular repair.
- TPA binds to fibrin--> activates plasminogen forming plasmin--> plasmin systematically degrades the fibrin clot into fragments (fibrin degradation product).
Tissue Plasminogen Activator (TPA)
- Binds to fibrin during polymerization.
- Initiates fibrinolysis by convering plasminogen--> plasmin.
- Free TPA circulates bound to inhibitor & cleared from plasma by the liver.
- Lyses the clot rather than prevents future clots.
- Synthetic TPA used clinically to dissolve clots/thrombi in stroke pts.
Urokinase
- Plasminogen activator
- Binds to fibrin during polymerization but does not bind firmly like TPA--> relatively minor physiologic effect.
Plasminogen Activator Inhibitor-1 (PAI-1)
- Fibrinolysis inhibitor
- Prevents activation of TPA & urokinase.
Thrombin Activable Fibrinolysis Inhibitor (TAFI)
- Activated by the thrombin-thrombomodulin complex.
- Prevents the binding of TPA & plasminogen to fibrin.
- Link between coagulation & fibrinolysis.
- Decrease thrombin production reduces activation of TAFI-->
- Increase thrombin generation increases the activation of TAFI-->
Fibrin Degradation Products.
- Inhibits hemostasis by preventing plt activation (primary) & fibrin polymerization (secondary).
D-dimer (D-D fragment)
- A specific marker for thrombosis.
- Used to identify DIC.
- Also used to rule out venous thromboembolism: deep vein thrombosis (DVT) & pulmonary embolism (PE).
Unique to the intrinsic pathway
Factors 12, 11, 9, & 8
Unique to the extrinsic pathway
Tissue factor & factor 7
Coagulation factors consumed during clotting
Fatcors 1, 3, 5, 8, & 13
Factors in Common Pathway
Factors 10, 5, 2, & 1